Questioning skeletal muscle index for muscle mass reduction assessment in computed tomography: Why square the height?

Computes Tomography (CT) scans are commonly used to assess muscle mass reduction by measuring skeletal muscle area (SMA) at the third lumbar vertebra (L3) level. The skeletal muscle index (SMI), which normalizes SMA by height squared, is the current reference standard for evaluating muscle mass redu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical nutrition (Edinburgh, Scotland) Jg. 52; S. 1 - 7
Hauptverfasser: Giai, Joris, Veloso, Mélanie, Vilotitch, Antoine, Charrière, Katia, Bétry, Cécile
Format: Journal Article
Sprache:Englisch
Veröffentlicht: England Elsevier Ltd 01.09.2025
Schlagworte:
Adult
Aged
Body Height
Body Mass Index
Female
Humans
Inpatients
Linear models
Male
Malnutrition
Middle Aged
Muscle, Skeletal - diagnostic imaging
Radiographic Tomography
Retrospective Studies
Sarcopenia
Sarcopenia - diagnostic imaging
Skeletal muscle index
Tomography, X-Ray Computed - methods
Radiographic Tomography
Skeletal muscle index
Sarcopenia
Inpatients
Malnutrition
Linear models
ISSN:0261-5614, 1532-1983, 1532-1983
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Computes Tomography (CT) scans are commonly used to assess muscle mass reduction by measuring skeletal muscle area (SMA) at the third lumbar vertebra (L3) level. The skeletal muscle index (SMI), which normalizes SMA by height squared, is the current reference standard for evaluating muscle mass reduction. However, recent studies suggest that SMI may not be the most reliable indicator due to its height dependency. This study aimed to assess the clinical relevance of different SMA-derived metrics to determine the most accurate measure of muscle mass reduction. This retrospective study included inpatients from a tertiary hospital who underwent abdominal CT scans. Skeletal muscle area (SMA) was measured using an AI-based software. The study population was divided into four groups based on age (≤40 years and >40 years) and gender. Four SMA-derived metrics were evaluated: SMI, skeletal muscle height (SMH, calculated as SMA divided by height), and Z-scores for both SMI and SMH (z(SMI) and z(SMH)). Pearson correlations between SMA-derived metrics and age, BMI, and height were calculated, alongside regression models to determine the optimal height scaling power. The study included 674 participants (362 males, 312 females), with a median age of 61 years and body mass index (BMI) of 24.7 kg/m2. BMI positively correlated with SMA, SMH, and SMI, but not with z(SMH) or z(SMI). SMH showed no significant correlation with height, except in males over 40. Linear regression for participants under 40 revealed height scaling coefficients of 1.547 (95 % CI: [0.736, 2.359]) for females and 0.982 (95 % CI: [0.047, 1.917]) for males. SMH could be a more suitable metric than SMI for assessing muscle mass reduction in CT scans, particularly due to its better independence from height. We emphasize the importance of clear terminology and recommend adopting “SMH” for SMA divided by height, to differentiate it from SMI in future studies.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0261-5614
1532-1983
1532-1983
DOI:10.1016/j.clnu.2025.07.010